EMA Publishes Nine PARs for Ancillary Drugs Included in Medical Devices

International Medical Device Regulatory Monitor
A A
In an effort at greater transparency, the European Medicines Agency (EMA) has begun publishing public assessment reports (PAR) for ancillary drug substances incorporated in medical devices.

To View This Article:

Login

Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00